<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00978315</url>
  </required_header>
  <id_info>
    <org_study_id>2009-010083-42</org_study_id>
    <nct_id>NCT00978315</nct_id>
  </id_info>
  <brief_title>Trial of Vitamin D Supplementation in Asthma</brief_title>
  <acronym>ViDiAs</acronym>
  <official_title>Randomised, Multi-centre, Double-blind, Placebo-controlled Trial of Vitamin D Supplementation in Adult and Adolescent Patients With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Health Service, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Barts &amp; The London NHS Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study null hypothesis is that vitamin D supplementation will not influence time to upper
      respiratory tract infection or time to severe asthma exacerbation in adult and adolescent
      patients with asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first upper respiratory tract infection</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to first severe asthma exacerbation</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Test Score</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to unscheduled health service use for upper respiratory tract infection or severe asthma exacerbation</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants experiencing hypercalcaemia</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Vigantol oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vigantol oil will be administered in 2-monthly oral bolus doses over a period of one year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Miglyol oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Miglyol oil will be administered in 2-monthly oral bolus doses over a period of one year</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>Cholecalciferol will be administered as 2-monthly oral bolus doses of Vigantol oil over a period of one year</description>
    <arm_group_label>Vigantol oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Miglyol oil</intervention_name>
    <description>Miglyol oil will be administered as 2-monthly oral bolus doses of Vigantol oil over a period of one year</description>
    <arm_group_label>Miglyol oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Principal Inclusion Criteria:

          -  Medical record diagnosis of asthma

          -  Age ≥ 16 years and ≤ 80 years on day of first dose of IMP

          -  If a woman of child-bearing potential, is sexually abstinent or has negative pregnancy
             test within 7 days of recruitment and agrees to use reliable form of contraception
             until she has completed the study

          -  Able to give written informed consent to participate in the study

        Principal Exclusion Criteria:

          -  Diagnosis of COPD

          -  Known sarcoidosis, hyperparathyroidism, nephrolithiasis, active tuberculosis, vitamin
             D intolerance, liver failure, renal failure, terminal illness, lymphoma or other
             malignancy not in remission for ≥ 3 years

          -  Any other condition that, in an investigator's judgement, might compromise patient
             safety or compliance, interfere with evaluation or preclude completion of the study

          -  Taking benzothiadiazine derivative, cardiac glycoside, carbamazepine, phenobarbital,
             phenytoin or primidone

          -  Taking dietary supplement containing vitamin D up to 2 months before first dose of IMP

          -  Treatment with any investigational medical product or device up to 4 months before
             first dose of IMP

          -  Breastfeeding, pregnant or planning a pregnancy

          -  Baseline corrected serum calcium &gt; 2.65 mmol/L

          -  Baseline serum creatinine &gt; 125 micromol/L

          -  Smoking history &gt;15 pack-years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian R Martineau, MRCP</last_name>
    <role>Study Director</role>
    <affiliation>Queen Mary University of London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barts and The London NHS Trust</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lower Clapton Health Centre</name>
      <address>
        <city>London</city>
        <zip>E5 0PD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Homerton University Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>E9 6SR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2009</study_first_submitted>
  <study_first_submitted_qc>September 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2009</study_first_posted>
  <last_update_submitted>February 3, 2014</last_update_submitted>
  <last_update_submitted_qc>February 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

